NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update
01. November 2024 16:50 ET
|
NurExone Biologic Inc
NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update
NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M
26. September 2024 16:03 ET
|
NurExone Biologic Inc
NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
28. August 2024 08:34 ET
|
NurExone Biologic Inc
NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update
NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility
25. April 2024 08:35 ET
|
NurExone Biologic Inc
NurExone Biologic Inc. Announces Strategic Expansion to US Financial Markets with Approval of OTCQB Listing Application and DTC Eligibility
NurExone's Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence
15. März 2024 16:05 ET
|
NurExone Biologic Inc
NurExone's Strategic Update: Submission of OTCQB Listing Application to Initiate US financial presence
NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million
05. Januar 2024 08:30 ET
|
NurExone Biologic Inc
NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million